mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 41, 2008, Pages 15914-15919

  Boukerche, Habib ^a,c   Su, Zao Zhong ^a   Prévot, Célia ^c   Sarkar, Devanand ^a,b   Fisher, Paul B ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c University Lyon 1   (France)

Author keywords

c Src siRNA; FAK; Signal transduction

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY RNA; FOCAL ADHESION KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN MDA 9; SMALL INTERFERING RNA; SYNTENIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENZYME ACTIVATION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MELANOMA, EXPERIMENTAL; NEOPLASM METASTASIS; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; RATS; RATS, WISTAR; SYNTENINS;

ADENOVIRIDAE; ANIMALIA;

EID: 57349141863     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0808171105     Document Type: Article

References (32)

1. Shah GD, Chapman PB (2007) Adjuvant therapy of melanoma. Cancer J 13:217-222.
2. Lin JJ, Jiang H, Fisher PB (1996) Characterization of a novel melanoma differentiation-associated gene, mda-9, that is down regulated during terminal differentiation. Mol Cell Differ 4:317-333.
3. Lin JJ, Jiang H, Fisher PB (1998) Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene. Gene 207:105-110.
4. Boukerche H, et al. (2005) mda-9/Syntenin: A positive regulator of melanoma metastasis. Cancer Res 65:10901-10911.
5. Helmke BM, et al. (2004) Melanomametastasis is associated with enhanced expression of the syntenin gene. Oncol Rep 12:221-228.
6. Koo TH, et al. (2002) Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines. Oncogene 21:4080-4088.
7. Sarkar D, Boukerche H, Su ZZ, Fisher PB (2008) mda-9/Syntenin: More than just a simple adapter protein when it comes to cancer metastasis. Cancer Res 68:3087-3093.
8. Sarkar D, Boukerche H, Su ZZ, Fisher PB (2004) mda-9/Syntenin: Recent insights into a novel cell signaling and metastasis-associated gene. Pharmacol Ther 104:101-115.
9. Boukerche H, Su ZZ, Emdad L, Sarkar D, Fisher PB (2007) mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB. Cancer Res 67:1812-1822.
10. Thomas SM, Brugge JS (1997) Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13:513-609.
11. Cary LA, Chang JF, Guan JL (1996) Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci 109:1787-1794.
12. Ishizawar R, Parsons SJ (2004) c-Src and cooperating partners in human cancer. Cancer Cell 6:209-214.
13. Irby RB, Yeatman TJ (2000) Role of Src expression and activation in human cancer. Oncogene 19:5636-5642.
14. Barnekow A, Paul E, Schartl M (1987) Expression of the c-src protooncogene in human skin tumors. Cancer Res 47:235-240.
15. Budde RJ, Ke S, Levin VA (1994) Activity of pp60c-src in 60 different cell lines derived from human tumors. Cancer Biochem Biophys 14:171-175.
16. Schaller MD, Hildebrand JD, Parsons JT (1999) Complex formation with focal adhesion kinase: A mechanism to regulate activity and subcellular localization of Src kinases. Mol Biol Cell 1:3489-3505.
17. Boukerche H, et al. (2000) A new Mr 55,000 surface protein implicated in melanoma progression: Association with a metastatic phenotype. Cancer Res 60:5848-5856.
18. Baril P, Nejjari M, Scoazek JY, Boukerche H (2002) Blocking a novel 55-kDa melanoma-associated cell surface antigen inhibits the development of spontaneous metastases and interactions with frozen lung section. Int J Cancer 99:315-322.
19. Zhao Y, Sudol M, Hanafusa H, Krueger J (1992) Increased tyrosine kinase activity of c-Src during calcium-induced keratinocyte differentiation. Proc Natl Acad Sci USA 89:8298-8302.
20. Sakamoto M, et al. (2001) Involvement of c-Src in carcinoma cell motility and metastasis. Jpn J Cancer Res 92:941-946.
21. Gonzalez L, et al. (2006) Role of c-Src in human MCF7 breast cancer cell tumorigenesis. J Biol Chem 281:20851-20864.
22. Fidler IJ, et al. (1991) Correlation of growth capacity of cells in hard agarose with successful transfection by the activated c-Ha-ras oncogene and in vivo proliferative capacity at metastatic sites. Anticancer Res 11:17-24.
23. Abbi S, Guan JL (2002) Focal adhesion kinase: Protein interactions and cellular functions. Histol Histopathol 17:1163-1171.
24. Mitra SK, Hanson DA, Schlaepfer DD (2005) Focal adhesion kinase: In command and control of cell motility. Nat Rev Mol Cell Biol 6:56-68.
25. Schaller MD, et al. (1994) Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol 14:1680-1688.
26. Cooper JA, MacAuley A (1988) Potential positive and negative autoregulation of p60c-src by intermolecular autophosphorylation. Proc Natl Acad Sci USA 85:4232-4236.
27. Tatosyan AG, Mizenina OA (2000) Kinases of the Src family: Structure and functions. Biochemistry 65:49-58.
28. Arias-Salgado EG, et al. (2003) Src kinase activation by direct interaction with the integrin beta cytoplasmic domain. Proc Natl Acad Sci USA 100:13298-13302.
29. Brunton VG, MacPherson IR, Frame MC (2004) Cell adhesion receptors, tyrosine kinases and actin modulators: A complex three-way circuitry. Biochim Biophys Acta 1692:121-144.
30. Hou XY, Zhang GY, Zong YY (2003) Suppression of postsynaptic density protein 95 expression attenuates increased tyrosine phosphorylation of NR2A subunits of Nmethyl-D-aspartate receptors and interactions of Src and Fyn with NR2A after transient brain ischemia in rat hippocampus. Neurosci Lett 343:125-128.
31. Matsuo Y, et al. (2006) Involvement of p38 alpha mitogen-activated protein kinase in lung metastasis of tumor cells. J Biol Chem 281:36767-36775.
32. Boukerche H, McGregor JL (1988) Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets. Eur J Biochem 171:383-392.